Pietro Manuel Ferraro1,2, Gary C Curhan3,4, Alessandro D'Addessi5, Giovanni Gambaro6. 1. Division of Nephrology, Fondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, Via Moscati 31-33, 00168, Rome, Italy. pietromanuel.ferraro@unicatt.it. 2. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. pietromanuel.ferraro@unicatt.it. 3. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 4. Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 5. Division of Urology, Fondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy. 6. Division of Nephrology, Fondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, Via Moscati 31-33, 00168, Rome, Italy.
Abstract
BACKGROUND: Nephrolithiasis is a frequent condition. While it is generally accepted that such condition carries a risk of recurrence over time, the exact risk and its predictors have been rarely quantitated. We aimed to estimate recurrence of kidney stones, overall and in specific subgroups, from randomized controlled trials (RCTs) of calcium stone formers. METHODS: Systematic review of RCTs of adult patients with idiopathic calcium kidney stones. Recurrence rates analyzed in subgroups based on type of intervention and other characteristics, using Poisson regression models. RESULTS: The analysis included 21 RCTs with 2168 participants over a median follow-up of 3.2 years (range 0.5-9.7). The median recurrence of kidney stones was 15 per 100 person-years (range 0-110). Recurrence was higher in those with two or more previous stone episodes compared to those with a single episode at enrolment (16 vs. 6 per 100 person-years, p < 0.001) and in those untreated or treated with dietary changes compared to those treated with drugs (26 vs. 23 vs. 9 per 100 person-years, p < 0.001). The effect of drugs on recurrence seemed to be beneficial only among those with two or more previous stone episodes. CONCLUSIONS: The overall recurrence rate of stones depends on factors such as previous stone history and type of treatment. Dietary approaches seem to be more effective among single stone formers, whereas drugs seem to be more effective among recurrent stone formers.
BACKGROUND:Nephrolithiasis is a frequent condition. While it is generally accepted that such condition carries a risk of recurrence over time, the exact risk and its predictors have been rarely quantitated. We aimed to estimate recurrence of kidney stones, overall and in specific subgroups, from randomized controlled trials (RCTs) of calcium stone formers. METHODS: Systematic review of RCTs of adult patients with idiopathic calciumkidney stones. Recurrence rates analyzed in subgroups based on type of intervention and other characteristics, using Poisson regression models. RESULTS: The analysis included 21 RCTs with 2168 participants over a median follow-up of 3.2 years (range 0.5-9.7). The median recurrence of kidney stones was 15 per 100 person-years (range 0-110). Recurrence was higher in those with two or more previous stone episodes compared to those with a single episode at enrolment (16 vs. 6 per 100 person-years, p < 0.001) and in those untreated or treated with dietary changes compared to those treated with drugs (26 vs. 23 vs. 9 per 100 person-years, p < 0.001). The effect of drugs on recurrence seemed to be beneficial only among those with two or more previous stone episodes. CONCLUSIONS: The overall recurrence rate of stones depends on factors such as previous stone history and type of treatment. Dietary approaches seem to be more effective among single stone formers, whereas drugs seem to be more effective among recurrent stone formers.
Authors: Giovanni Gambaro; Maria Luisa Valente; Edoardo Zanetti; Mila Della Barbera; Dorella Del Prete; Angela D'Angelo; Andrea Trevisan Journal: J Am Soc Nephrol Date: 2006-06-21 Impact factor: 10.121
Authors: Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga Journal: Ann Intern Med Date: 2013-04-02 Impact factor: 25.391
Authors: Matthew R D'Costa; William E Haley; Kristin C Mara; Felicity T Enders; Terri J Vrtiska; Vernon M Pais; Steven J Jacobsen; Cynthia H McCollough; John C Lieske; Andrew D Rule Journal: J Am Soc Nephrol Date: 2019-06-07 Impact factor: 10.121
Authors: Pietro Manuel Ferraro; Miguel Ángel Arrabal-Polo; Giovambattista Capasso; Emanuele Croppi; Adamasco Cupisti; Thomas Ernandez; Daniel G Fuster; Juan Antonio Galan; Felix Grases; Ewout J Hoorn; Felix Knauf; Emmanuel Letavernier; Nilufar Mohebbi; Shabbir Moochhala; Kremena Petkova; Agnieszka Pozdzik; John Sayer; Christian Seitz; Pasquale Strazzullo; Alberto Trinchieri; Giuseppe Vezzoli; Corrado Vitale; Liffert Vogt; Robert J Unwin; Olivier Bonny; Giovanni Gambaro Journal: Urolithiasis Date: 2019-03-08 Impact factor: 3.436
Authors: G Gambaro; D S Goldfarb; R Baccaro; J Hirsch; N Topilow; S D'Alonzo; G Gambassi; P M Ferraro Journal: J Nephrol Date: 2018-02-21 Impact factor: 3.902
Authors: Lisa E Vaughan; Felicity T Enders; John C Lieske; Vernon M Pais; Marcelino E Rivera; Ramila A Mehta; Terri J Vrtiska; Andrew D Rule Journal: Mayo Clin Proc Date: 2018-12-04 Impact factor: 7.616
Authors: Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg Journal: Transplantation Date: 2017-08 Impact factor: 4.939